Yes. One of the things that has surprised me on positive side is how enthusiastic the clinicians I have spoken to have been about Bisantrene - I really didn’t expect this given the market perception that Bisantrene is a boring old chemo drug.
The enthusiasm for Bisantrene with clinicians has only grown as we have been generating new science and clinical results.
RAC Price at posting:
96.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)